WALVAX BIOTECHNOLOGY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.36 CNY | -0.14% |
|
-6.81% | -38.92% |
| Apr. 26 | Walvax Biotechnology's Profit Drops 92%, Operating Income Slids 28% in Q1 2024 | MT |
| Apr. 25 | Walvax Biotechnology's Unit to End COVID-19 Vaccine Trial | MT |
Evolution of the average Target Price on Walvax Biotechnology Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
8ee805571a8dc56.DoobVBNTKbeVgblx99b02zBB9w7N2BPdrR46NMXa85k.PeFRJnIFRYXX6Yk7rbijuX0UxXr76FXsnnVpAfKsnNpf8Fc-ewwd4Mby-A~be2eebac069777fa781000ed949267a3
Analysts' Consensus
Sell
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
14.36
CNY
Average target price
20
CNY
Spread / Average Target
+39.28%
High Price Target
25
CNY
Spread / Highest target
+74.09%
Low Price Target
15
CNY
Spread / Lowest Target
+4.46%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C+
EPS Revisions
- Stock Market
- Equities
- 300142 Stock
- Consensus Walvax Biotechnology Co., Ltd.
